Cryo-Cell International News

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersTevogen Bio Holdings (NASDAQ:TVGN) shares rose 75.3% to $1.49 during Friday's pre-market session. The company's market cap stands at $245.2 million. Cryo-Cell International (AMEX:CCEL) shares i

BenzingaApr 26 08:06 ET

CRYO-CELL International GAAP EPS of $0.07 Beats by $0.13, Revenue of $7.85M Misses by $0.1M

Seeking AlphaApr 16 03:36 ET

Cryo-Cell International Q1 EPS $0.07 Beats $(0.02) Estimate, Sales $7.85M Miss $7.93M Estimate

Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.02) by 450 percent. This is a 22.22 percent decrease over earnings

BenzingaApr 15 17:05 ET

Express News | Cryo-Cell International Q1 Revenue USD 7.85 Million

Moomoo 24/7Apr 15 17:00 ET

Express News | Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results

Moomoo 24/7Apr 15 17:00 ET

NYSE American New 52-Week Highs And Lows

New Highs 2 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ Cryo-Cell International CCEL 8.11 8,975 FT

Dow JonesMar 27 10:19 ET

Cryo-Cell International Announces Strategic Subsidiary Spin-Off Plans

TipRanksMar 26 08:44 ET

Express News | Cryo-Cell Announces Plans To Explore Strategic Alternatives And Spin-off Celle Corp

Moomoo 24/7Mar 25 09:03 ET

Cryo-Cell International: A Buy Rating Anchored in Strong Gross Margins and Long-Term Growth Prospects

TipRanksMar 2 07:45 ET

CRYO-CELL International GAAP EPS of -$1.14 Misses by $1.26, Revenue of $31.3M Misses by $0.08M

Seeking AlphaFeb 28 17:43 ET

Cryo-Cell International FY23 Rev $31.3M >CCEL

Cryo-Cell International FY23 Rev $31.3M >CCEL

Dow JonesFeb 28 17:01 ET

Press Release: Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 OLDSMAR, Fla.--(BUSINESS WIRE)--February 28, 2024-- Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"

Dow JonesFeb 28 17:00 ET

Strong Performance and Growth Potential Drive Buy Rating for Cryo-Cell International: An Analysis by Allen Klee

TipRanksOct 14, 2023 13:25 ET

Cryo-Cell International Q3 EPS $0.08 Vs. $0.06 Prior Year, Sales $7.87M Beat $7.77M Estimate

Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.08 per share. This is a 33.33 percent increase over earnings of $0.06 per share from the same period last year. The company repo

BenzingaOct 12, 2023 16:49 ET

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results

Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the "Company"), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended

BusinesswireOct 12, 2023 16:45 ET

CRYO-CELL International GAAP EPS of $0.03, Revenue of $7.77M

Seeking AlphaJul 17, 2023 07:29 ET

Cryo-Cell International Q2 EPS $0.03 Beats $(0.08) Estimate, Sales $7.77M Inline

Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.08) by 137.5 percent. This is a 57.14 percent decrease over earnin

BenzingaJul 14, 2023 16:17 ET

Express News | Cryo-Cell International 2Q EPS 3c >CCEL

Moomoo 24/7Jul 14, 2023 16:17 ET

Express News | Cryo-Cell International 2Q Rev $7.77M >CCEL

Moomoo 24/7Jul 14, 2023 16:17 ET

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results

Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31,

BusinesswireJul 14, 2023 16:15 ET